8-67506804-G-C

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2

The NM_020361.5(CPA6):​c.619C>G​(p.Gln207Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00198 in 1,611,506 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0012 ( 0 hom., cov: 32)
Exomes š‘“: 0.0021 ( 4 hom. )

Consequence

CPA6
NM_020361.5 missense

Scores

2
10
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:9B:3

Conservation

PhyloP100: 8.97
Variant links:
Genes affected
CPA6 (HGNC:17245): (carboxypeptidase A6) The gene encodes a member of the peptidase M14 family of metallocarboxypeptidases. The encoded preproprotein is proteolytically processed to generate the mature enzyme, which catalyzes the release of large hydrophobic C-terminal amino acids. This enzyme has functions ranging from digestion of food to selective biosynthesis of neuroendocrine peptides. Mutations in this gene may be linked to epilepsy and febrile seizures, and a translocation t(6;8)(q26;q13) involving this gene has been associated with Duane retraction syndrome. [provided by RefSeq, May 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CPA6NM_020361.5 linkc.619C>G p.Gln207Glu missense_variant Exon 6 of 11 ENST00000297770.10 NP_065094.3 Q8N4T0-1
CPA6XM_017013646.2 linkc.175C>G p.Gln59Glu missense_variant Exon 6 of 11 XP_016869135.1
CPA6XM_017013647.2 linkc.619C>G p.Gln207Glu missense_variant Exon 6 of 7 XP_016869136.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CPA6ENST00000297770.10 linkc.619C>G p.Gln207Glu missense_variant Exon 6 of 11 1 NM_020361.5 ENSP00000297770.4 Q8N4T0-1

Frequencies

GnomAD3 genomes
AF:
0.00122
AC:
186
AN:
152174
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00219
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00146
AC:
366
AN:
251082
Hom.:
0
AF XY:
0.00153
AC XY:
207
AN XY:
135684
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.00186
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00244
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00206
AC:
3001
AN:
1459214
Hom.:
4
Cov.:
29
AF XY:
0.00202
AC XY:
1466
AN XY:
726034
show subpopulations
Gnomad4 AFR exome
AF:
0.000239
Gnomad4 AMR exome
AF:
0.00210
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000197
Gnomad4 FIN exome
AF:
0.000112
Gnomad4 NFE exome
AF:
0.00248
Gnomad4 OTH exome
AF:
0.00186
GnomAD4 genome
AF:
0.00122
AC:
186
AN:
152292
Hom.:
0
Cov.:
32
AF XY:
0.00106
AC XY:
79
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.000337
Gnomad4 AMR
AF:
0.00105
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000942
Gnomad4 NFE
AF:
0.00219
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.00163
Hom.:
1
Bravo
AF:
0.00124
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00151
AC:
13
ExAC
AF:
0.00147
AC:
179
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:9Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial temporal lobe epilepsy 5 Pathogenic:1Uncertain:2
Dec 14, 2012
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Feb 01, 2018
Baylor Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not provided Uncertain:3
Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 25, 2018
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 04, 2021
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Reported in cis with G267R in an individual with early onset epileptic encephalopathy, inherited from the individual's mother who was reported to have unexplained epilepsy but not epileptic encephalopathy (Allen et al., 2016) Reported in an individual with temporal lobe epilepsy who was also heterozygous for the G267R variant, but familial segregation information was not included (Sapio et al., 2012) In silico analysis supports that this missense variant has a deleterious effect on protein structure/function This variant is associated with the following publications: (PMID: 32581362, 29358611, 23105115, 26648591) -

not specified Uncertain:1Benign:1
Jan 03, 2024
Athena Diagnostics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 15, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: CPA6 c.619C>G (p.Gln207Glu) results in a conservative amino acid change located in the Peptidase M14, carboxypeptidase A domain (IPR000834) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.002 in 1611506 control chromosomes in the gnomAD database, including 4 homozygotes, suggesting the variant could be benign. c.619C>G has been reported in the literature in individuals of heterozygous or unspecified genotype affected with neurodevelopmental disorders including focal or progressive myoclonic epilepsy, early onset epileptic encephalopathy, intellectual disability, cerebral palsy, or other unspecified neurodevelopmental disorder all without evidence of causality, often found in cis or unknown phase with c.799G>A, p.G267R (e.g. Sapio_2012, Muona_2014, Allen_2015, Moortgat_2018, vanEyk_2021, Sanchis-Juan_2023, Coppola_2023). These reports do not provide unequivocal conclusions about association of the variant with CPA6-Related Disorders. At least one publication reports experimental evidence evaluating an impact on protein function showing severely reduced CPA6 activity and protein expression in vitro (e.g. Sapio_2012). The following publications have been ascertained in the context of this evaluation (PMID: 26648591, 38088023, 29180823, 25401298, 37541188, 23105115, 34531397). ClinVar contains an entry for this variant (Variation ID: 393467). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -

Febrile seizures, familial, 11 Benign:2
Apr 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Molecular Genetics Lab, CHRU Brest
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Self-limited epilepsy with centrotemporal spikes Pathogenic:1
Jan 01, 2017
Bioinformatics Core, Luxembourg Center for Systems Biomedicine
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: case-control

CAADphred>15 -

Confusion;C0030252:Palpitations;C0036572:Seizure;C0156404:Irregular menstruation;C0751495:Focal-onset seizure;C4020949:Abnormal emotional state;C5399973:Periventricular heterotopia Pathogenic:1
-
NIHR Bioresource Rare Diseases, University of Cambridge
Significance: Likely pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Global developmental delay Uncertain:1
Feb 21, 2017
Claritas Genomics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Familial temporal lobe epilepsy 5;C3280734:Febrile seizures, familial, 11 Uncertain:1
Jun 21, 2021
New York Genome Center
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The inherited missense variant c.619C>G (p.Gln207Glu) in the CPA6 gene has been reported in the literature in individuals affected with epilepsy [PMIDs: 21922598, 23105115, 26648591]. The variant has 0.001222 allele frequency in the gnomAD(v3) database (186 out of 152174 heterozygous alleles, no homozygotes). It affects evolutionarily conserved residues and is predicted deleterious by multiple in silico prediction tools. In vitro functional expression studies in cellular assays suggest that the variant reduces the CPA6 enzymatic activity compared to wild type protein [PMIDs: 21922598, 23105115]. However, additional studies are needed to determine the clinical significance of this variant. Based on the available evidence, the inherited heterozygous missense variants [c.619C>G(p.Gln207Glu)identified in the CPA6 gene is reported as a variant of uncertain significance. -

Epilepsy Uncertain:1
Nov 10, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.040
CADD
Pathogenic
31
DANN
Uncertain
0.99
DEOGEN2
Benign
0.064
T
Eigen
Pathogenic
0.70
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.88
D
M_CAP
Uncertain
0.27
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.70
N
PrimateAI
Uncertain
0.56
T
PROVEAN
Uncertain
-2.5
N
REVEL
Uncertain
0.48
Sift
Uncertain
0.014
D
Sift4G
Uncertain
0.015
D
Polyphen
0.98
D
Vest4
0.91
MVP
0.39
MPC
0.16
ClinPred
0.040
T
GERP RS
5.3
Varity_R
0.82
gMVP
0.92

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.22
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.22
Position offset: 3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35993949; hg19: chr8-68419039; COSMIC: COSV99913489; API